WO2003092088-A3  BORSINI F ET AL: "Behavioral effects of flibanserin ( BIMT 17 )." PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, (1999 SEP) 64 (1) 137-46., XP001055977;  EVANS, S. E. GILBERT (1) ET AL: "The effects of flibanserin on amphetamine withdrawal-induced hypolocomotion in rats." SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1998) VOL. 24, NO. 1-2, PP. 2133. MEETING INFO.: 28TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, PART 2 LOS ANGELES, CALIFORNIA, USA NOVEMBER 7-12, 1998 SOCIETY FOR NEUROSCIENCE., XP001062815;  GUPTA Y K ET AL: "THERAPEUTIC POTENTIALS OF 5-HT RECEPTOR MODULATORS" INDIAN JOURNAL OF PHARMACOLOGY, XX, XX, vol. 26, no. 2, 1 June 1994 (1994-06-01), pages 94-107, XP000571272 ISSN: 0253-7613;  BORSINI F ET AL: "BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex." NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, (1995 SEP) 352 (3) 276-82., XP001057819;  PODHORNA J ET AL: "Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety." BRITISH JOURNAL OF PHARMACOLOGY, (2000 JUN) 130 (4) 739-46., XP001057715;  BORSINI F ET AL: "Behavioral effects of flibanserin ( BIMT 17 ).", PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, (1999 SEP) 64 (1) 137-46., XP001055977;  EVANS, S. E. GILBERT (1) ET AL: "The effects of flibanserin on amphetamine withdrawal-induced hypolocomotion in rats.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1998) VOL. 24, NO. 1-2, PP. 2133. MEETING INFO.: 28TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, PART 2 LOS ANGELES, CALIFORNIA, USA NOVEMBER 7-12, 1998 SOCIETY FOR NEUROSCIENCE., XP001062815;  GUPTA Y K ET AL: "THERAPEUTIC POTENTIALS OF 5-HT RECEPTOR MODULATORS", INDIAN JOURNAL OF PHARMACOLOGY, XX, XX, vol. 26, no. 2, 1 June 1994 (1994-06-01), pages 94 - 107, XP000571272, ISSN: 0253-7613;  BORSINI F ET AL: "BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.", NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, (1995 SEP) 352 (3) 276-82., XP001057819;  PODHORNA J ET AL: "Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety.", BRITISH JOURNAL OF PHARMACOLOGY, (2000 JUN) 130 (4) 739-46., XP001057715;  BORSINI F ET AL: "Behavioral effects of flibanserin ( BIMT 17 ).", PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, (1999 SEP) 64 (1) 137-46., XP001055977,relevantClaims[1,14-16,19-21|1-23],relevantPassages[&lt;pp&gt;141&lt;/pp&gt;&lt;ppl&gt;142&lt;/ppl&gt;&lt;figure&gt;1,2&lt;/figure&gt;&lt;table&gt;3,4&lt;/table&gt;];  EVANS, S. E. GILBERT (1) ET AL: "The effects of flibanserin on amphetamine withdrawal-induced hypolocomotion in rats.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1998) VOL. 24, NO. 1-2, PP. 2133. MEETING INFO.: 28TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, PART 2 LOS ANGELES, CALIFORNIA, USA NOVEMBER 7-12, 1998 SOCIETY FOR NEUROSCIENCE., XP001062815,relevantClaims[1,5-9],relevantPassages[&lt;pp&gt;A&lt;/pp&gt;];  GUPTA Y K ET AL: "THERAPEUTIC POTENTIALS OF 5-HT RECEPTOR MODULATORS", INDIAN JOURNAL OF PHARMACOLOGY, XX, XX, vol. 26, no. 2, 1 June 1994 (1994-06-01), pages 94 - 107, XP000571272, ISSN: 0253-7613,relevantClaims[1-23],relevantPassages[&lt;pp&gt;99&lt;/pp&gt;];  BORSINI F ET AL: "BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.", NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, (1995 SEP) 352 (3) 276-82., XP001057819,relevantClaims[1-23],relevantPassages[&lt;pp&gt;A&lt;/pp&gt;]